Omec.ai

Omec.aiOmec.ai
O

Omec.ai

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

DR 0.12022InactiveBoston, United States
Rate

About

Omec.ai leverages artificial intelligence and machine learning to enhance the efficiency and success rates of drug discovery and development processes. Their platform aims to help pharmaceutical and biotech companies identify novel drug candidates, optimize preclinical studies, and accelerate clinical trials.
Frequently asked

What does Omec.ai do?

Omec.ai leverages artificial intelligence and machine learning to enhance the efficiency and success rates of drug discovery and development processes. Their platform aims to help pharmaceutical and biotech companies identify novel drug candidates, optimize preclinical studies, and accelerate clinical trials.

What is Omec.ai's revenue?

StartupHub estimates Omec.ai's annual revenue at $3.4M (range $820K to $5.1M, 27% confidence), based on comparable companies in the sector.

What is Omec.ai's valuation?

StartupHub estimates Omec.ai's effective valuation at $43.8M (range $30.0M to $72.0M, 10% confidence), based on comparable companies in the sector.

How much funding has Omec.ai raised?

Omec.ai has raised a total of $12M in funding. The most recent round on record is Seed.

Where is Omec.ai headquartered?

Omec.ai is headquartered in Boston, United States.

When was Omec.ai founded?

Omec.ai was founded in 2022.

What industry does Omec.ai operate in?

Omec.ai operates in Life Sciences, Biotech, Drug Discovery, HealthTech, AI-Driven Drug Discovery, Pharmaceuticals.

What is Omec.ai's current status?

Omec.ai's current operating status is: Inactive.

Comments

No comments yet. Be the first to share your take.